Page 82 - MSU Digital Book

17. Ekberg H, Tedesco-Silva H, Demirbas A, Vítko S, Nashan B, Gürkan A, et al; ELITE-

Symphony Study. Reduced exposure to calcineurin inhibitors in renal
transplantation. N Engl J Med. 2007;357:2562-75.
18. Webster A, Woodroffe RC, Taylor RS, Chapman JR, Craig JC. Tacrolimus versus

cyclosporin as primary immunosuppression for kidney transplant recipients.
Cochrane Database Syst Rev. 2005;CD003961.

19. Wagner M, Earley AK, Webster AC, Schmid CH, Balk EM, Uhlig K. Mycophenolic acid
versus azathioprine as primary immunosuppression for kidney transplant recipients.
Cochrane Database Syst Rev. 2015;CD007746.

20. European Mycophenolate Mofetil Cooperative Study Group. Placebo-controlled
study of mycophenolate mofetil combined with cyclosporin and corticosteroids

for prevention of acute rejection. Lancet. 1995;345:1321-5.
21. Li P, Shuker N, Hesselink DA, van Schaik RH, Zhang X, van Gelder T. Do Asian renal
transplant patients need another mycophenolate mofetil dose compared with

Caucasian or African American patients? Transpl Int. 2014;27:994-1004.
22. Julasareekul W, Eiam-Ong S, Bejraputra O, Seublinvong T. Pharmacokinetics of

mycophenolic acid in kidney transplant recipients treated with a low dose (1 gram/
day) of mycophenolate mofetil. J Med Assoc Thai. 2003;86:766.
23. Jirasiritham S, Sumethkul V, Mavichak V, Na-Bangchang K. The pharmacokinetics

of mycophenolate mofetil in Thai kidney transplant recipients. Transplant
Proc. 2004;36:2076.

24. Webster AC, Lee VW, Chapman JR, Craig JC. Target of rapamycin inhibitors (sirolimus
and everolimus) for primary immunosuppression of kidney transplant recipients:
a systematic review and meta-analysis of randomized trials. Transplantation.

2006;81:1234-48.
25. Lim WH, Eris J, Kanellis J, Pussell B, Wiid Z, Witcombe D, et al. A systematic

review of conversion from calcineurin inhibitor to mammalian target of rapamycin
inhibitors for maintenance immunosuppression in kidney transplant recipients. Am
J Transplant. 2014;14:2106-19.

26. Haller MC, Royuela A, Nagler EV, Pascual J, Webster AC. Steroid avoidance or
withdrawal for kidney transplant recipients. Cochrane Database Syst Rev.

2016;CD005632.

57